Sólido margen EBIT ajustado del 18,8 %, impulsado por un firme crecimiento orgánico de los ingresos del 7,4 %

EarningsPositive

AI Analysis

Summary

CERS reported H1 2026 results with organic revenue growth of 7.4% and adjusted EBIT margin of 18.8%, driven by growth in both pet animals (+10.0%) and farm animals segments.

Financial Highlights

Revenue

+7.4% organic growth

Importance:3/10

Sentiment:

0.60

earningsH1_2026_resultsrevenue_growthprofitabilitypet_animals_segmentfarm_animals_segment

Read the original article

Published by PR Newswire Pharma on September 18, 2026 11:27 AM

Read Original